ADDIS ABABA, Ethiopia, November 14, 2016
- Merck  kicks off their social media campaign to raise awareness about diabetes  early detection and prevention as part of Merck Capacity Advancement  Program - CAP
 
- Merck Diabetes Award aims to build diabetes experts platform in partnership with African and Asian universities
 
Merck (www.MerckGroup.com),  a leading science and technology company, today announced the winners  of the Merck Diabetes Award “Every Day is a Diabetes Day” to mark the  World Diabetes Day- WDD themed ‘Eyes on Diabetes’.
Merck Diabetes Award as part of the Merck Capacity Advancement Program (www.Merck-CAP.com)  was launched in April 2016 in partnership with African and Asian  universities with the aim of building a platform of diabetes experts  across the globe.
“Merck plays an important role in building  Diabetes Care capacity in partnership with African and Asian  Universities. Today marks an important day in the fight against Diabetes  as we celebrate World Diabetes Day. In this context, we have announced  ten Diabetes Award Winners from Africa and Asia” says Belen Garijo,  Member of Merck's Executive Board and CEO Merck Healthcare. “This  initiative fully illustrates our commitment to improving access to  affordable Healthcare in Africa and other developing countries” Garijo  added.
The scientific committee received over 500 concept  submission applications from universities in Africa and Asia and 10  winners were selected for the award. The winner from each university has  been granted a one year postgraduate diabetes diploma in South Wales  University, United Kingdom.
“Merck Diabetes Award marks  another step in our long term commitment to support diabetes care  strategies in developing countries through working with local  governments, academia and relevant stakeholders in building healthcare  capacity with a focus on Diabetes, hypertension and other  non-communicable diseases in various countries in Asia-Pacific, Middle  East, Africa and Latin America” said Rasha Kelej, Chief Social Officer,  Merck Healthcare when making the announcement of the winners.
Merck  invited all medical students to apply for the “Merck Diabetes Award”  2016 with the theme “Every Day is a Diabetes Day”. Students across  African and Asian medical universities were asked to submit a concept  paper on how to improve diabetes early detection and prevention in their  countries and how to encourage their society, scientific community,  local authorities, media and relevant stakeholders to think and act on  diabetes every day.
“Access to diabetic care in Africa will  slowly grow with the initiation of this award, because it will create  ‘diabetes scholars’ with more insight and knowledge on the best care  needed for patients and how to facilitate it,” said Dominic  Oduro-Donkor, from Cape Coast Teaching Hospital, Ghana and a Merck  Diabetes Award winner.
“The Merck Capacity Advancement Programme  is a ground-breaking initiative to control this growing epidemic of  non-communicable diseases (NCDs) like diabetes, by motivating and  sensitising undergraduate students and giving them a chance to gain an  in-depth knowledge about every aspect of this disease,” emphasized one  of the winners Antara Bagchi, a student at the Indira Gandhi Medical  College, India.
Ahmed Reja, the President of International  Diabetes Federation, Africa and President of Ethiopia Diabetes  Association emphasized: “We are very happy to partner with Merck to  drive their strategy to build diabetes capacity and roll out the Merck  Diabetes Award across the continent. The awards encourage the students  to be more innovative and take a leadership position to fight diabetes  in their own country.”
In addition, as part of its recognition of  the World Diabetes Day, the Merck Capacity Advancement Program also  launched its European Accredited Clinical Diabetes and Hypertension  management 2016 tour across Africa and Asia. The program supports  focused training to build diabetes healthcare capacity for medical  undergraduates, postgraduates and healthcare providers in partnership  with universities across the two continents.
More than 5000  medical undergraduates have benefited from the fourth edition of the  Merck Capacity Advancement Program which covered eight African countries  and is in partnership with Addis Ababa University, Ethiopia; University  of Nairobi, Kenya; Makerere University, Uganda; Muhimbili University,  Tanzania; University of Ghana; University of Namibia; Eduardo Mondelane  University in Mozambique and Agostinho Neto University, Angola. In Asia  the tours are being conducted with Maharashtra University, India and  University of Indonesia.
#MerckDiabetesTips 
In  addition to building capacity among healthcare professionals to provide  quality diabetes care, Merck runs a social media campaign providing  diabetes patient education through videos and information materials in  English, French, Portuguese, Spanish, and many local languages focusing  on diabetes early symptoms and complications to raise awareness on  diabetes and the importance of early detection and prevention among  communities.
To Know More about Merck Diabetes Award: Read below 
Meet the winners of Merck Diabetes Award 2016 from African and Asian universities:
Elisha Kipkemoi Ngetich 
College of Health Sciences, University of Nairobi, Kenya
“I  am ecstatic at winning the Merck Diabetes Award 2016. I thank Merck for  providing this wonderful platform where students can further their  studies in non-communicable diseases. With the current surge in the  prevalence of diabetes in Kenya and other developing countries, the  timing of this award could not have been better. Over the years, I have  developed an interest in diabetes because I have seen patients in the  different stages of this disease. I have also seen the impact that early  recognition and management of this disease can have and I am privileged  to broaden my understanding of the disease through this postgraduate  diploma course. This will also build me academically and professionally  as well. This is the kind of initiative that Kenya and Africa at large  needs, an initiative to empower young doctors and other healthcare  professionals. This information then trickles down to the patients and  ultimately we end up with a healthy Kenya and Africa. I am convinced  that the knowledge I will gather during this experience will  significantly impact on my practice in the near future and hence a  better outcome for our diabetic patients.”
Ralph Obure 
College of Health Sciences, University of Nairobi, Kenya
“The  Kenyan healthcare system faces new challenges in diabetes and other  non-communicable diseases and so efforts by Merck to increase capacity  are timely and highly welcome. I am honoured to receive the Merck  Diabetes Award that will advance my medical career and enable me to  provide the much needed expertise in diabetes management in Kenya.”
Antara Bagchi
Indira Gandhi Government Medical College, Nagpur, India
“Merck  is providing an opportunity for the care and control of diabetes in the  community especially in Asia and Africa, where non-communicable  diseases are becoming increasingly prevalent. The Merck Capacity  Advancement Programme is a ground-breaking initiative to control this  rampant and growing epidemic of NCDs like diabetes, by motivating and  sensitising undergraduate students like us, and giving them a chance to  gain an in-depth, holistic knowledge about every aspect of this disease.  I am sure that this initiative will have a profound impact on the  health scenario, and the incidence and morbidity of NCDs will be lowered  significantly.”
 
Samuel Mucheru
Aga Khan University, Kenya
“This  award is important to me because it marks the start of a future career  in diabetes management which I am very passionate about. It will help  build diabetes expertise in my country, which is badly needed due to the  exponential increase in diabetes cases within the population. Moreover,  it will help achieve the wider goal of building capacity in diabetes  management especially in the low and middle income countries whose  non-communicable disease burden is on an upward trend without a  commensurate increase in the number of experts to deal with this  pandemic.”
Tinka George
Makerere University College of Health Sciences, Uganda
“I  am grateful and happy that Merck has provided us with this great  opportunity to advance our knowledge in diabetes. This opportunity of  increasing the number of diabetes specialists will step up efforts in  the fight against this 'silent killer', especially here in Africa where  the burden of the disease is skyrocketing day and night. This will help  save many lives.”
Gloria Ani-asamoah
Accra, Ghana
“It  is a privilege to acquire current knowledge in the management of  diabetes. It is my hope that at the end of this course l will be a  better advocate in diabetes prevention and offer comprehensive diabetes  care. The time is now to curb the menace of disease.”
Nujood Al Shirawi
Intern, Dubai Health Authority, United Arab Emirates
“Diabetes  is a lifelong illness which affects the lives of more than 14% adults  in UAE. With such a high percentage, everybody in the UAE knows  individuals battling diabetes. I am grateful to Merck and Dubai Medical  College for enabling the young doctors in the region to participate in  such a program where a platform has been created for exchange of  knowledge between national and international experts. I am looking  forward to the diabetes diploma and believe it will add to my existing  knowledge and help develop my understanding of this illness which  affects nearly every organ in the body. It was a wonderful experience to  be part of this award and I would encourage all my colleagues to  participate in any future events.”
Najmah Kuddah
General Practitioner, University of Indonesia, Indonesia
“Indonesia  is the fifth largest population with diabetes, yet 73.7% is undiagnosed  because of lack of awareness. One of them could be someone we love.  This award means everything to me, so I can do something for my family,  people and my country”.
Dominic Oduro-Donkor
Cape Coast Teaching Hospital, Ghana
“In  Ghana many people do not have access to healthcare services in order to  identify, diagnose and treat diabetes and its complications. It is  essential to achieve adequate diabetes care as the number of people  living with the condition continues to escalate. There is also a need to  commit resources to diabetes education across Ghana and the African  continent at large. Until this happens large numbers of people will end  up experiencing potentially preventable diabetes-related complications  such as blindness, kidney failure and amputation.
The reason why this  award is important to me is because Merck has given me an opportunity  to take my trade outside the consulting room and making it possible for  me to help more people, to make my voice louder and to help those who  can’t help themselves.
Access to diabetic care in Africa will slowly  grow with the initiation of this award, because it will create ‘diabetes  scholars’ who will have more insight and knowledge on the best care  needed for patients and how to facilitate it. Together, our voices will  resonate the need for change and improved management strategies, which  will change the face of diabetes care in Africa. The mobilization of  professionals across the continent of Africa is the first step in  forming a platform where ideas can be put across and shared to make  diabetic care easily accessible.”
 
Ken Munene Nkonge
University of Nairobi, Kenya
“Similar  to other countries in Africa, majority of people living with diabetes  in Kenya are diagnosed late, when the options available for preventing  complications of the disease are few and suboptimal. I strongly believe  that community-based preventative measures alongside early diagnosis and  management of prediabetes and related comorbidities such as obesity and  hypertension are essential to reducing the burden of type 2 diabetes on  Kenya’s health care system. The Merck Diabetes Award is important to me  because it will empower me with the knowledge and skills needed to make  this belief a reality across Kenya. As the recipient of this award, I  look forward to this amazing opportunity.”
Watch the below videos of diabetes patients from India, Indonesia and Africa sharing their experience with diabetes
Watch Bhupendra Jaiswal, a diabetes patient in India as he talks about his experience: https://www.youtube.com/watch?v=ON5q7i9pDlk
Watch Suresh Varpe, a diabetes patient in India as he talks about his experience: https://www.youtube.com/watch?v=ON5q7i9pDlk
Watch Ibu Omik, an Indonesian diabetes patient as she shares her experience: https://www.youtube.com/watch?v=lKSuclTCLcM 
Watch Tego Wagimin, an Indonesian diabetes patient as he talks about his experience: https://www.youtube.com/watch?v=0eBmGHfYnyI 
Watch the experience of Zena Ali, a woman living with diabetes in Kibera, Kenya: https://www.youtube.com/watch?v=_sucYtW5BVc
Watch  the below Diabetes Patient Awareness Videos #MerckDiabetesTips symptoms  and complication in English, French, Portuguese, and local languages
Watch Merck Africa-diabetes detection and prevention patient education tips in English: https://www.youtube.com/watch?v=AeTip7eI30A 
Merck Capacity Advancement Program-diabetes detection and prevention patient education tips in French: https://youtu.be/ecgC-xlZn90
Merck Capacity Advancement Program-diabetes detection & prevention patient education tips in Portuguese: https://youtu.be/nAyvXTTQIx0
Watch Merck India diabetes detection and prevention patient education tips in Hindi: https://www.youtube.com/watch?v=kRDELKUjpac
Watch Merck India diabetes detection and prevention patient education tips in Marathi: https://www.youtube.com/watch?v=t4H7Z__LYlE
Watch Merck Indonesia diabetes detection and prevention patient education tips in Bahasa: https://www.youtube.com/watch?v=j3pC-64h-Xo
Watch Merck Africa diabetes detection and prevention patient education tips in Kiswahili: https://www.youtube.com/watch?v=isi5ThqhNt8
Watch  medical students’ testimonies about Merck Capacity Advancement Program  and Merck Diabetes Award from United Arab Emirates, India and Africa
Watch  medical students at the Dubai Medical University as they share their  ideas on how to improve diabetes awareness in United Arab Emirates to  apply for Merck Diabetes Award:
https://www.youtube.com/watch?v=uFRcSEC6fRU
Watch testimonies of Medical Students from India on the benefits of Merck Capacity Advancement Program: https://youtu.be/SvIF_JetKO4 
Watch testimonies of students from the University of Nairobi, Kenya on the benefits of the Merck Capacity Advancement Program: http://youtu.be/JZVJwmtr7ng
More about Merck Capacity Advancement Program on Social Media: 
Twitter: using the hadle @MerckCAP (https://twitter.com/MerckCAP) or the hastag #MerckDiabetesTips (http://APO.af/FGt9Dw)
Facebook: Merck Capacity Advancement Program (http://APO.af/ORmAsE)
YouTube: Merck Capacity Advancement Program (http://APO.af/sQP5jU)
About the Merck Capacity Advancement Program (CAP):
Merck  CAP is a 5-year program aiming to expand the professional capacity in  developing countries in the areas of research and development, advocacy  building, supply-chain integrity and efficiency, pharmacovigilance,  medical education, and community awareness. It was established in 2012.
As  part of the CAP, more than 17,000 medical students from Angola,  Ethiopia, Ghana, Kenya, Mozambique, Namibia, Tanzania and Uganda in  addition to Asian universities such as Maharashtra University, India and  University of Indonesia have benefited from this program and we aim to  reach 25,000 by 2018. 
Please go to www.Merck-CAP.com and www.Merck-Africa.com for more information. 
About Merck:
Merck  (MerckGroup.com) is a leading science and technology company in  healthcare, life science and performance materials. Around 50,000  employees work to further develop technologies that improve and enhance  life – from biopharmaceutical therapies to treat cancer or multiple  sclerosis, cutting-edge systems for scientific research and production,  to liquid crystals for smartphones and LCD televisions. In 2015, Merck  generated sales of € 12.85 billion in 66 countries.
Founded in 1668,  Merck is the world's oldest pharmaceutical and chemical company. The  founding family remains the majority owner of the publicly listed  corporate group. Merck, Darmstadt, Germany holds the global rights to  the Merck name and brand. The only exceptions are the United States and  Canada, where the company operates as EMD Serono, MilliporeSigma and EMD  Performance Materials.
More photos from Merck Diabetes Award 2016 are available here: www.APO-mail.org/161114Merck